AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 102 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $14,000 | -26.3% | 22,600 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $19,000 | +26.7% | 22,600 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $15,000 | -21.1% | 22,600 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $19,000 | -47.2% | 22,600 | 0.0% | 0.00% | -75.0% |
Q4 2018 | $36,000 | -52.0% | 22,600 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $75,000 | +47.1% | 22,600 | 0.0% | 0.01% | +20.0% |
Q2 2018 | $51,000 | -22.7% | 22,600 | 0.0% | 0.01% | -16.7% |
Q1 2018 | $66,000 | +4.8% | 22,600 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $63,000 | -23.2% | 22,600 | 0.0% | 0.01% | -33.3% |
Q3 2017 | $82,000 | – | 22,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
Caption Management, LLC | 855,200 | $701,000 | 0.04% |
Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |